Evaxion A (EVAX) Tax Provisions (2020 - 2026)
Evaxion A (EVAX) reported Tax Provisions of $216000.0 for Q1 2026, up 12.5% on a YoY basis from $192000.0 in Q1 2025, and down 15.29% quarter-over-quarter from $255000.0 in Q4 2025.
Evaxion A (EVAX) Tax Provisions (2020 - 2026) Analysis & Trends
Evaxion A has reported Tax Provisions for 7 years, with the latest figure at $216000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 12.5% year-over-year to $216000.0; the trailing twelve-month figure through Mar 2026 stood at $931000.0 (up 22.18% YoY), and the FY2025 full-year result was $908000.0, up 15.23% from the prior year.
- Tax Provisions for Q1 2026 stood at $216000.0, down from $255000.0 in the prior quarter.
- The five-year high for Tax Provisions was $275000.0 in Q4 2024, with the low at $96000.0 in Q3 2024.
- Historically, Tax Provisions has averaged $204294.1 across 5 years, with a median of $195000.0 in 2025.
- Annual changes were most pronounced in 2022 — Tax Provisions plunged 73.54% — and 2025, when it jumped 176.04%.
- Evaxion A's Tax Provisions stood at $173000.0 in 2022, then rose by 2.31% to $177000.0 in 2023, then soared by 55.37% to $275000.0 in 2024, then declined by 7.27% to $255000.0 in 2025, then retreated by 15.29% to $216000.0 in 2026.
- The last three Tax Provisions figures came in at $216000.0 (Q1 2026), $255000.0 (Q4 2025), and $265000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 104.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 195,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | 218,000.00 |
| Dec 31, 2023 | 177,000.00 |
| Sep 30, 2023 | 194,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 194,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 177,000.00 |
| Mar 31, 2022 | 247,000.00 |
| Dec 31, 2021 | -1.32 Mn |
| Sep 30, 2021 | 425,000.00 |
| Jun 30, 2021 | 669,000.00 |